Trials / Conditions / Low Grade Ovarian Serous Adenocarcinoma
Low Grade Ovarian Serous Adenocarcinoma
4 registered clinical trials studyying Low Grade Ovarian Serous Adenocarcinoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO) NCT06494150 | University of Oklahoma | Phase 2 |
| Active Not Recruiting | A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian NCT04625270 | Verastem, Inc. | Phase 2 |
| Completed | Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer NCT00551070 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors NCT00488878 | M.D. Anderson Cancer Center | — |